Adherence to topical medication in patients with inflammatory eye disease

Research output: Contribution to journalArticlepeer-review


  • Hedayat Javidi
  • Nat Poonit
  • Radhika P Patel

Colleges, School and Institutes

External organisations

  • Inflammatory Eye Disease Service, Birmingham & Midland Eye Centre, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
  • Academic Unit of Ophthalmology, Institute of Inflammation & Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.


Purpose: To evaluate adherence to topical medication in patients with inflammatory eye disease.

Methods: Questionnaire survey of patients attending inflammatory eye disease clinics. Treatment regimen was validated against hospital-generated clinic letters.

Results: There were 86 patients (52 uveitis and 34 ocular surface disease) with 30% (26/86) failing to identify one or more of the medications they were using, and 28% (24/86) unable to offer the correct indication for their treatment. A total of 64% (55/86) failed to use their medication as advised (27% on a daily basis); the commonest reason being forgetfulness. In patients using multiple eye drops, 26% left insufficient time intervals between successive eye drops, and 58% (50/86) reported not being given any instruction on drop instillation.

Conclusions: We highlight poor adherence to topical medication in patients with inflammatory eye disease. We recommend a dedicated practitioner providing a proactive approach to patient education to improve adherence.


Original languageEnglish
JournalOcular immunology and inflammation
Publication statusPublished - 16 Jan 2020


  • Adherence, ocular surface disease, patient education, topical medication, uveitis

ASJC Scopus subject areas